Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients
Public ClinicalTrials.gov record NCT00082628. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Serostim®, r-hGH in the Treatment and Maintenance of Human Immunodeficiency HIV-Associated Adipose Redistribution Syndrome, or HARS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to determine if Serostim® 4 mg administered daily for 12 weeks as treatment for the abnormal fat accumulation and distribution associated with HIV-associated Adipose Redistribution Syndrome (HARS) reduces Visceral Adipose Tissue (VAT, measured by CT scan) more effectively than placebo.
Study identification
- NCT ID
- NCT00082628
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 326 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 28, 2004 (Actual)
- Primary completion
- Sep 28, 2005 (Actual)
- Completion
- Sep 28, 2005 (Actual)
- Last update posted
- Jul 20, 2018
2004 – 2005
United States locations
- U.S. sites
- 30
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama/Birmingham | Birmingham | Alabama | 35294 | — |
| CARE CLINIC - UCLA Medical Center | Los Angeles | California | 90095 | — |
| 1401 N. Palm Canyon | Palm Springs | California | 92262 | — |
| Trials Unit Div of Infectious and Immunologic Diseases | Sacramento | California | 95817 | — |
| UCSD - AntiViral Research Center | San Diego | California | 92103 | — |
| University of California, San Francisco - Div. of Endocrinology | San Francisco | California | 94110 | — |
| Kaiser Permanente | San Francisco | California | 94118 | — |
| Northern California Institute for Research and Education, Inc. | San Francisco | California | 94121 | — |
| Harbor-UCLA Medical Ctr Research & Education Institute | Torrance | California | 90502 | — |
| AIDS Alliance | West Hollywood | California | 90069 | — |
| University of Colorado Health Sciences Center | Denver | Colorado | 80262 | — |
| 1640 Rhode Island Avenue, N.W. | Washington D.C. | District of Columbia | 20036 | — |
| Office Of Dr Gary Richmond | Fort Lauderdale | Florida | 33316 | — |
| 3661 South Miami Avenue | Miami | Florida | 33133 | — |
| Care Resources | Miami | Florida | 33137 | — |
| Infectious Disease Associates | Sarasota | Florida | 34239 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Indiana University Infectious Disease Research Clinic | Indianapolis | Indiana | 46202 | — |
| Tufts University School of Medicine | Boston | Massachusetts | 02111 | — |
| Community Research Initiative of New England | Boston | Massachusetts | 02215 | — |
| Community Research Initiative Of New England | Springfield | Massachusetts | 01107 | — |
| Hennepin County Medical Center | Minneapolis | Minnesota | 55415 | — |
| Albany Medical College | Albany | New York | 12208 | — |
| Weill Medical College of Cornell Universtiy | New York | New York | 10021 | — |
| St. Luke's Roosevelt Hospital | New York | New York | 10025 | — |
| Bronx Women's Interagency HIV Study | The Bronx | New York | 10467 | — |
| Central Texas Clincial research | Austin | Texas | 78705 | — |
| IDP Research | Annandale | Virginia | 22003 | — |
| Office of Daniel Coulston, M.D. | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00082628, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2018 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00082628 live on ClinicalTrials.gov.